Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Kim BY, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE.

J Neurooncol. 2014 Jun;118(2):405-12. doi: 10.1007/s11060-014-1451-0. Epub 2014 Apr 29.

PMID:
24777756
[PubMed - in process]
2.

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, Shonka N, Gilbert MR, Sawaya R, Prabhu SS, Weinberg J, Lang FF, Aldape KD, Sulman EP, Rao G, McCutcheon IE, Cahill DP.

Neuro Oncol. 2014 Jan;16(1):81-91. doi: 10.1093/neuonc/not159. Epub 2013 Dec 4.

PMID:
24305719
[PubMed - indexed for MEDLINE]
3.

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A.

Acta Neuropathol. 2010 Dec;120(6):707-18. doi: 10.1007/s00401-010-0781-z. Epub 2010 Nov 19.

PMID:
21088844
[PubMed - indexed for MEDLINE]
4.

Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status.

Ohno M, Narita Y, Miyakita Y, Okita Y, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Kayama T, Shibui S.

Brain Tumor Pathol. 2012 Oct;29(4):183-91. doi: 10.1007/s10014-012-0113-1. Epub 2012 Jul 13.

PMID:
22790483
[PubMed - indexed for MEDLINE]
5.

Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.

McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI.

Neurosurgery. 2008 Jul;63(1):55-60; discussion 60-1. doi: 10.1227/01.NEU.0000335070.37943.09.

PMID:
18728568
[PubMed - indexed for MEDLINE]
6.

IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.

Thota B, Shukla SK, Srividya MR, Shwetha SD, Arivazhagan A, Thennarasu K, Chickabasaviah YT, Hegde AS, Chandramouli BA, Somasundaram K, Santosh V.

Am J Clin Pathol. 2012 Aug;138(2):177-84. doi: 10.1309/AJCPZOIY3WY4KIKE.

PMID:
22904127
[PubMed - indexed for MEDLINE]
Free Article
7.

[Correlation between IDH1 mutation and prognosis in supratentorial high-grade astrocytomas].

Xie F, Tang JJ, Wang X, Liu YH, Mao Q.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Mar;44(2):184-7, 192. Chinese.

PMID:
23745251
[PubMed - in process]
8.

No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas.

Ahmadi R, Stockhammer F, Becker N, Hohlen K, Misch M, Christians A, Dictus C, Herold-Mende C, Capper D, Unterberg A, von Deimling A, Wick W, Hartmann C.

J Neurooncol. 2012 Aug;109(1):15-22. doi: 10.1007/s11060-012-0863-y. Epub 2012 Apr 19.

PMID:
22528790
[PubMed - indexed for MEDLINE]
9.

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.

Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C.

Acta Neuropathol. 2009 Sep;118(3):401-5. doi: 10.1007/s00401-009-0550-z. Epub 2009 Jun 19.

PMID:
19543740
[PubMed - indexed for MEDLINE]
10.

The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.

Majchrzak K, Kaspera W, Bobek-Billewicz B, Hebda A, Stasik-Pres G, Majchrzak H, Ładziński P.

Clin Neurol Neurosurg. 2012 Oct;114(8):1135-44. doi: 10.1016/j.clineuro.2012.02.054. Epub 2012 Mar 17.

PMID:
22425370
[PubMed - indexed for MEDLINE]
11.

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.

Thon N, Eigenbrod S, Kreth S, Lutz J, Tonn JC, Kretzschmar H, Peraud A, Kreth FW.

Cancer. 2012 Jan 15;118(2):452-60. doi: 10.1002/cncr.26298. Epub 2011 Jun 29.

PMID:
21717448
[PubMed - indexed for MEDLINE]
Free Article
12.

Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.

McGirt MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ, Olivi A, Quiñones-Hinojosa A.

Neurosurgery. 2008 Aug;63(2):286-91; discussion 291. doi: 10.1227/01.NEU.0000315282.61035.48.

PMID:
18797358
[PubMed - indexed for MEDLINE]
13.

Serum GFAP is a diagnostic marker for glioblastoma multiforme.

Jung CS, Foerch C, Schänzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M.

Brain. 2007 Dec;130(Pt 12):3336-41. Epub 2007 Nov 12.

PMID:
17998256
[PubMed - indexed for MEDLINE]
Free Article
14.

CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation.

Bianco AM, Uno M, Oba-Shinjo SM, Clara CA, de Almeida Galatro TF, Rosemberg S, Teixeira MJ, Nagahashi Marie SK.

Pathol Oncol Res. 2014 Jun 27. [Epub ahead of print]

PMID:
24970694
[PubMed - as supplied by publisher]
15.

Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach.

Sipayya V, Sharma I, Sharma KC, Singh A.

J Cancer Res Ther. 2012 Oct-Dec;8(4):598-601. doi: 10.4103/0973-1482.106567.

PMID:
23361281
[PubMed - indexed for MEDLINE]
16.

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.

Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL.

Neurosurgery. 1997 Nov;41(5):1028-36; discussion 1036-8.

PMID:
9361056
[PubMed - indexed for MEDLINE]
17.

Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.

Babu R, Bagley JH, Park JG, Friedman AH, Adamson C.

J Neurosurg. 2013 Aug;119(2):434-41. doi: 10.3171/2013.4.JNS122329. Epub 2013 May 10.

PMID:
23662821
[PubMed - indexed for MEDLINE]
18.

Cordotomy for patients with thoracic malignant astrocytoma.

Nakamura M, Tsuji O, Fujiyoshi K, Watanabe K, Tsuji T, Ishii K, Matsumoto M, Toyama Y, Chiba K.

J Neurosurg Spine. 2010 Oct;13(4):418-23. doi: 10.3171/2010.4.SPINE09901.

PMID:
20887138
[PubMed - indexed for MEDLINE]
19.

Prognostic value of IDH1 mutations identified with PCR-RFLP assay in glioblastoma patients.

Bujko M, Kober P, Matyja E, Nauman P, Dyttus-Cebulok K, Czeremszyńska B, Bonicki W, Siedlecki JA.

Mol Diagn Ther. 2010 Jun 1;14(3):163-9. doi: 10.2165/11537170-000000000-00000.

PMID:
20560678
[PubMed - indexed for MEDLINE]
20.

IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value?

Buccoliero AM, Castiglione F, Degl'Innocenti DR, Gheri CF, Genitori L, Taddei GL.

Fetal Pediatr Pathol. 2012 Oct;31(5):278-82. doi: 10.3109/15513815.2012.659383. Epub 2012 Mar 20.

PMID:
22432788
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk